Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Sunrest Lifescience

₹78 0 | 0%

Market Cap ₹33 Cr.

Stock P/E

P/B 2.4

Current Price ₹78

Book Value ₹ 32.5

Face Value 10

52W High ₹84

Dividend Yield 0%

52W Low ₹ 57.4

Sunrest Lifescience Research see more...

Overview Inc. Year: 2017Industry: Trading

Sunrest Lifescience Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Peer Comparison

Sunrest Lifescience Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Sunrest Lifescience Profit & Loss

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 11 17 27 25
Other Income 0 0 0 0
Total Income 11 17 27 25
Total Expenditure 11 17 26 22
Operating Profit 0 0 1 3
Interest 0 0 0 0
Depreciation 0 0 0 0
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 0 0 1 3
Provision for Tax 0 0 0 1
Profit After Tax 0 0 1 2
Adjustments 0 0 0 0
Profit After Adjustments 0 0 1 2
Adjusted Earnings Per Share 0.1 0.6 2.6 6.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -7% 31% 0% 0%
Operating Profit CAGR 200% 0% 0% 0%
PAT CAGR 100% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 98% 96% 79% 79%
ROCE Average 59% 33% 26% 26%

Sunrest Lifescience Balance Sheet

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 0 0 1 3
Minority's Interest 0 0 0 0
Borrowings 2 2 3 2
Other Non-Current Liabilities -0 -0 -0 -0
Total Current Liabilities 4 7 9 12
Total Liabilities 6 9 13 17
Fixed Assets 0 0 0 0
Other Non-Current Assets 0 0 0 0
Total Current Assets 6 9 13 16
Total Assets 6 9 13 17

Sunrest Lifescience Cash Flow

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0
Cash Flow from Operating Activities -1 0 -0 1
Cash Flow from Investing Activities -0 -0 -0 -0
Cash Flow from Financing Activities 1 0 1 -1
Net Cash Inflow / Outflow 0 0 0 -0
Closing Cash & Cash Equivalent 0 0 0 0

Sunrest Lifescience Ratios

# Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.12 0.55 2.59 6.81
CEPS(Rs) 0.18 0.7 2.79 7.24
DPS(Rs) 0 0 0 0
Book NAV/Share(Rs) 0.43 0.98 3.57 10.38
Core EBITDA Margin(%) 1.4 1.62 4.13 11.79
EBIT Margin(%) 1.25 1.37 3.99 11.38
Pre Tax Margin(%) 1.25 1.32 3.91 11.14
PAT Margin (%) 0.34 0.98 2.89 8.29
Cash Profit Margin (%) 0.48 1.23 3.11 8.82
ROA(%) 0.59 2.11 6.91 13.75
ROE(%) 28.44 78.01 113.7 97.59
ROCE(%) 5.72 9.26 31.03 58.59
Receivable days 179.1 137.56 113.68 149.63
Inventory Days 15.84 21.5 25.91 46.19
Payable days 175.04 159.98 149.9 203.03
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.18 0.12 0.1 0.19
EV/Core EBITDA(x) 12.66 7.1 2.44 1.6
Net Sales Growth(%) 0 54.76 58.64 -8.35
EBIT Growth(%) 0 69.1 362.84 161.04
PAT Growth(%) 0 349.73 369.55 162.91
EPS Growth(%) 0 349.73 369.55 162.91
Debt/Equity(x) 17.54 7.85 3.02 0.69
Current Ratio(x) 1.62 1.35 1.42 1.41
Quick Ratio(x) 1.49 1.13 1.16 1.07
Interest Cover(x) 457.33 27.62 45.89 47.43
Total Debt/Mcap(x) 0 0 0 0

Sunrest Lifescience Shareholding Pattern

# Mar 2024
Promoter 69.91
FII 0
DII 0
Public 30.09
Others 0
Total 100

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 96%
  • Company has reduced debt.

Cons

  • Debtor days have increased from 149.9 to 203.03days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Sunrest Lifescience News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....